DAX6.693-1,4%  Dow12.775-0,9%  Euro1,3182-0,8% 
ESt502.481-1,7%  Nas2.906-0,7%  Öl117,3-1,2% 
TDax769,9-0,4%  Nikkei8.947-0,6%  Gold1.720-0,6% 

MGI Pharma Aktie [WKN: 867545 / ISIN: US5528801062]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
Börsenplätze Kursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur MGI Pharma Inc.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

ALLE Nachrichten zur MGI Pharma Inc.

28.01.08Eisai Completes Acquisition of MGI PHARMA
26.01.08Eisai Announces Completion of Tender Offer for MGI Pharma Shares
23.01.08Eisai Announces Satisfaction of Conditions to Tender Offer for MGI PHARMA Shares
18.01.08MGI PHARMA Announces Results from Study Involving the Dual Implantation of Gliadel(R) Wafer and Radioactive Seeds for Treatment of Recurrent Glioblastoma Multiforme
17.01.08Eisai and MGI PHARMA Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI PHARMA
07.01.08Notice of Correction to Notice of Conversion Right for Senior Subordinated Convertible Notes Due 2024
03.01.08MGI PHARMA and HELSINN Announce sNDA for Aloxi Capsules Accepted for Review by U.S. FDA
26.12.07Notice of Conversion Right for Senior Subordinated Convertible Notes Due 2024
21.12.07Eisai Commences Cash Tender Offer for All Outstanding Shares of MGI PHARMA
17.12.07MGI PHARMA Announces Aquavan NDA Accepted for Review by U.S. FDA
10.12.07Dacogen(R) (Decitabine) for Injection Data Presented at the American Society of Hematology (ASH) 49th Annual Meeting and Exposition
10.12.07Wall Street-Schluss: Deutliche Zugewinne, Gute Laune vor morgiger Zinsentscheidung
10.12.07Wall Street Update: Deutliche Zugewinne, Warten auf Fed-Entscheidung
10.12.07Wall Street: Freundlicher Wochenauftakt, MGI Pharma im Höhenflug, McDonald's verbucht Umsatzplus
10.12.07Börsen in Asien: Überwiegend schwächer, Eisai übernimmt MGI Pharma
10.12.07Eisai übernimmt MGI Pharma für 3,9 Mrd. Dollar
10.12.07Eisai to Acquire MGI PHARMA for $41 Per Share in an All Cash Transaction
29.11.07MGI PHARMA Issues Statement
27.11.07MGI PHARMA To Present at The BMO Capital Markets 7th Annual Focus on Healthcare Conference
20.11.07MGI PHARMA To Present at the Lazard Capital Markets 4th Annual Healthcare Conference
29.10.07MGI PHARMA and HELSINN Announce Submission of Supplemental New Drug Application for Aloxi(R) Capsules
22.10.07Aquavan(R) Phase 3 Bronchoscopy Data Presented At CHEST 2007
17.10.07MGI PHARMA Reports Third Quarter 2007 Financial Results
15.10.07Aloxi(R) Phase 3 Data for Post Operative Nausea and Vomiting (PONV) Presented at the Annual Meeting of the American Society of Anesthesiologists (ASA)
11.10.07AkaRx and MGI PHARMA Announce Closing of Development and License Agreement
10.10.07MGI PHARMA Third Quarter 2007 Financial Results Conference Call to Be Webcast on October 17, 2007
27.09.07MGI PHARMA Announces Submission of Aquavan(R) New Drug Application
19.09.07MGI PHARMA Announces Change to Presentation Time at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices Conference
18.09.07MGI PHARMA to Present at the UBS Global Life Sciences Conference
12.09.07MGI PHARMA to Present at the Merrill Lynch Global Pharmaceutical Biotechnology and Medical Devices Conference
04.09.07MGI PHARMA and HELSINN Announce Aloxi(R) sNDA Approval Allowing for Repeated Dosing for Cancer Patients Receiving Multiple Day Chemotherapy Regimens
04.09.07MGI PHARMA to Present at the Bear Stearns 20th Annual Healthcare Conference
28.08.07MGI PHARMA Signs Agreement for Rights to Novel Treatment for Thrombocytopenia
18.07.07MGI PHARMA Reports Second Quarter 2007 Financial Results
11.07.07MGI PHARMA Second Quarter 2007 Financial Results Conference Call to Be Webcast on July 18, 2007
09.07.07MGI PHARMA and HELSINN Announce Aloxi sNDA for PONV Accepted for Review By U.S. FDA
04.06.07MGI PHARMA Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting
24.05.07MGI PHARMA to Present at the Bank of America Healthcare Conference
23.05.07Aquavan(R) (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
07.05.07MGI PHARMA and HELSINN Announce Submission of Supplemental New Drug Application for Aloxi(R) Injection in Post-Operative Nausea and Vomiting

Anzeige

ANZEIGE